STOCK TITAN

Hercules Capital, Inc. - HTGC STOCK NEWS

Welcome to our dedicated page for Hercules Capital news (Ticker: HTGC), a resource for investors and traders seeking the latest updates and insights on Hercules Capital stock.

Hercules Capital, Inc. (NYSE: HTGC) is a premier specialty finance company dedicated to providing senior secured loans to high-growth, venture capital-backed companies in technology-related markets. Established in December 2003, Hercules has positioned itself as a key player in the venture lending space, committing over $4.6 billion to more than 300 companies across various stages of development. The company focuses on sectors such as technology, biotechnology, life sciences, and sustainable and renewable energy.

Hercules Capital stands out by offering more than just financial support. The company provides vital access to its expansive network of contacts and invaluable business advice, helping entrepreneurial companies achieve significant milestones. Their investment portfolio includes a mix of structured debt with warrants, senior debt, and equity investments.

Recent achievements include a $35 million loan facility to SynOx Therapeutics Limited to support the development of emactuzumab, a next-generation monoclonal antibody for treating Tenosynovial Giant Cell Tumour (TGCT). Another notable investment is the $150 million financing to Harness, a Modern Software Delivery Platform company, to expand its platform with new modules and enhance its use of generative AI.

Hercules Capital’s strategic partnerships and financial solutions make it the lender of choice for venture-backed companies seeking reliable growth capital. The company’s financial stability and extensive industry expertise ensure that it remains a trusted partner for innovation-driven businesses looking to scale.

Rhea-AI Summary
Hercules Capital, Inc. (NYSE: HTGC) reported a strong financial performance for Q4 2023 and full-year 2023 with record total investment income, net investment income, and gross fundings. The company also announced a supplemental cash distribution for 2024 and had over $1.0 billion of available liquidity. With approximately $4.2 billion of assets under management, Hercules showed a significant increase year-over-year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.85%
Tags
-
Rhea-AI Summary
Hercules Capital, Inc. (HTGC) declares a total cash distribution of $0.48 per share for the fourth quarter of 2023, consisting of a base distribution of $0.40 per share and a new supplemental distribution of $0.08 per share. The company's Board of Directors aims to distribute 90% to 100% of its taxable quarterly income or potential annual income for the year. The distribution payment dates are set for February 28, 2024, and March 6, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
-
Rhea-AI Summary
Hercules Capital, Inc. (HTGC) announces a new supplemental cash distribution of $0.32 per share to be distributed over four quarters, starting with $0.08 per share for the fourth quarter of 2023. This is in addition to the regular quarterly cash distribution of $0.40 per share. The company's Board of Directors aims to distribute 90-100% of taxable income quarterly.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
none
Rhea-AI Summary
Hercules Capital, Inc. (NYSE: HTGC) has announced the schedule for its fourth quarter and full-year 2023 financial results conference call on February 15, 2024. The call will be available via telephone and live webcast, with an archived webcast replay available for at least 30 days. Investors and stakeholders can register to participate in the call and access the necessary details.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.99%
Tags
-
Rhea-AI Summary
enGene Holdings Inc. (ENGN) secures a $50 million loan agreement with Hercules Capital, Inc. (HTGC) to support the development of their lead EG-70 program for BCG-unresponsive non-muscle invasive bladder cancer. The loan has a term of four years, with $22.5 million already advanced and up to a further $27.5 million available based on clinical and financial milestones. The capital will extend the company's cash runway and support operations beyond the anticipated EG-70 interim data readout.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.52%
Tags
none
-
Rhea-AI Summary
Revelation Partners (NYSE: RP) announced the addition of Andrew Olson as Partner, Chief Financial Officer and Chief Operating Officer. With over $1.5 billion of capital under management, the firm has recently closed its $608 million Fund IV, reflecting the growing deal activity in private healthcare companies. Andrew Olson brings 17 years of experience in leadership roles in private and public companies, enhancing the firm's technical expertise and supporting its differentiated investment model.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.32%
Tags
none
Rhea-AI Summary
Hercules Capital, Inc. (NYSE: HTGC) has received a 'green light' letter from the U.S. Small Business Administration to submit an application for a fourth Small Business Investment Company (SBIC) subsidiary. This will enable Hercules to access an additional $175.0 million of long-term debentures, bringing its combined borrowing capacity through the SBIC program to a total of $350.0 million of capital. The company's CEO, Scott Bluestein, emphasized the importance of this partnership in maintaining a highly liquid and diversified balance sheet, providing flexibility to support small and growth-oriented businesses.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
none
-
Rhea-AI Summary
Hercules Capital, Inc. (NYSE: HTGC) announced its executive management team's participation in upcoming financial community events, including the Jefferies 8th Annual BDC Summit, 2023 JMP Securities BDC Summit, and SMBC Annual BDC Fixed Income Investor Event. Investors can arrange participation and meetings with management through Jefferies, JMP Securities, and SMBC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.82%
Tags
none
-
Rhea-AI Summary
Hercules Capital, Inc. reported strong financial results for Q3 2023. Total Investment Income reached $116.7 million, a 38.6% YoY increase. Net Investment Income (NII) was $76.8 million, or $0.52 per share, up 53.6% YoY. Year-to-date Gross Fundings were $1.29 billion, a 17.7% YoY increase. Q3 2023 NII provided 130% coverage of the Base Cash Distribution. The company has approximately $4.1 billion of Assets Under Management, a 19.4% YoY increase.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.43%
Tags
Rhea-AI Summary
Hercules Capital, Inc. announces a total cash distribution of $0.48 per share for the third quarter of 2023, consisting of a $0.40 per share base distribution and an $0.08 per share supplemental distribution. The distribution payment will be made on November 22, 2023. The company aims to distribute approximately 90% to 100% of its taxable quarterly income or potential annual income. The tax attributes of the distributions are determined annually based on the company's full-year taxable income.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.05%
Tags

FAQ

What is the current stock price of Hercules Capital (HTGC)?

The current stock price of Hercules Capital (HTGC) is $19.21 as of December 20, 2024.

What is the market cap of Hercules Capital (HTGC)?

The market cap of Hercules Capital (HTGC) is approximately 3.2B.

What does Hercules Capital, Inc. specialize in?

Hercules Capital specializes in providing senior secured loans to venture capital-backed companies in technology-related industries.

Which industries does Hercules Capital, Inc. focus on?

Hercules Capital focuses on technology, biotechnology, life sciences, and sustainable and renewable energy sectors.

How much has Hercules Capital, Inc. committed since its inception?

Since its inception in December 2003, Hercules Capital has committed over $4.6 billion to more than 300 companies.

What kind of financial products does Hercules Capital, Inc. offer?

Hercules Capital offers a mix of structured debt with warrants, senior debt, and equity investments.

Can you provide an example of a recent investment by Hercules Capital, Inc.?

A recent investment by Hercules Capital includes a $35 million loan facility to SynOx Therapeutics Limited for developing emactuzumab.

Why do companies choose Hercules Capital, Inc.?

Companies choose Hercules Capital for its reliable growth capital, access to an extensive network of contacts, and valuable business advice.

How does Hercules Capital, Inc. support its portfolio companies beyond financial investment?

Beyond financial investment, Hercules Capital offers access to a wide network of contacts and essential business advice to help companies achieve key milestones.

What is a notable recent achievement of Hercules Capital, Inc.?

A notable recent achievement is the $150 million financing to Harness to support the expansion of their software delivery platform.

How does Hercules Capital, Inc. ensure its financial stability?

Hercules ensures financial stability through strategic partnerships, diversified investment portfolios, and deep industry expertise.

What is the significance of Hercules Capital, Inc. in the venture lending space?

Hercules Capital is a leading lender of choice for entrepreneurs and venture capital firms, highlighted by its extensive commitments and successful partnerships with high-growth companies.

Hercules Capital, Inc.

NYSE:HTGC

HTGC Rankings

HTGC Stock Data

3.19B
164.61M
1.82%
26.98%
3.49%
Asset Management
Financial Services
Link
United States of America
SAN MATEO